Anti-neovascular medicines

Summary

The tender concerns the supply of anti-neovascular medicines and azacitidine. The contract is planned to start on 1 February 2027. The notice indicates that e-invoicing is required and that bids must be submitted electronically. The machine-readable notice does not provide precise qualification or exclusion requirements, so these must be checked in the tender documents.